Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)
NCT00796419
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Lung Injury, Acute (ALI)
Respiratory Distress Syndrome, Acute (ARDS)
Interventions
DRUG:
5% human albumin
DRUG:
6% hetastarch
Sponsor
Emory University